Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Hormone or other secreted growth regulatory factor,...
Reexamination Certificate
2006-05-23
2006-05-23
Romeo, David (Department: 1647)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Hormone or other secreted growth regulatory factor,...
C435S377000, C435S365000, C435S368000, C530S399000, C514S012200
Reexamination Certificate
active
07048934
ABSTRACT:
This invention relates to a method of selectively producing neural cells, including neurons or glial cells, in vitro or in vivo. Also provided are methods of treating or ameliorating neurodegenerative disease or medical conditions by producing neural cells. Thus, a combination of factors is used to achieve two steps: increasing the number of neural stem cells and instructing the neural stem cells to selectively become neurons or glial cells.
REFERENCES:
patent: 5023252 (1991-06-01), Hseih
patent: 5128242 (1992-07-01), Arimura et al.
patent: 5198542 (1993-03-01), Onda et al.
patent: 5208320 (1993-05-01), Kitada et al.
patent: 5268164 (1993-12-01), Kozarich et al.
patent: 5326860 (1994-07-01), Onda et al.
patent: 5506107 (1996-04-01), Cunningham et al.
patent: 5506206 (1996-04-01), Kozarich et al.
patent: 5527527 (1996-06-01), Friden
patent: 5547935 (1996-08-01), Mullenbach et al.
patent: 5559143 (1996-09-01), McDonald et al.
patent: 5614184 (1997-03-01), Sytkowski et al.
patent: 5623050 (1997-04-01), Kitada et al.
patent: 5686416 (1997-11-01), Kozarich et al.
patent: 5723115 (1998-03-01), Serrero
patent: 5750376 (1998-05-01), Weiss et al.
patent: 5753506 (1998-05-01), Johe
patent: 5773569 (1998-06-01), Wrighton et al.
patent: 5801147 (1998-09-01), Kitada et al.
patent: 5833988 (1998-11-01), Friden
patent: 5837460 (1998-11-01), Von Feldt et al.
patent: 5851832 (1998-12-01), Weiss et al.
patent: 5877169 (1999-03-01), Simpkins
patent: 5885574 (1999-03-01), Elliott
patent: 5955346 (1999-09-01), Wells et al.
patent: 5977307 (1999-11-01), Friden et al.
patent: 5980885 (1999-11-01), Weiss et al.
patent: 6015555 (2000-01-01), Friden
patent: 6048971 (2000-04-01), Sytkowski et al.
patent: 6191106 (2001-02-01), Mullenbach et al.
patent: 6239105 (2001-05-01), Brewitt
patent: 6242563 (2001-06-01), Dong
patent: 6329508 (2001-12-01), Friden
patent: 6333031 (2001-12-01), Olsson et al.
patent: 6413952 (2002-07-01), Luengo et al.
patent: 6429186 (2002-08-01), Fuh et al.
patent: 2002/0098178 (2002-07-01), Brand
patent: WO 96 40231 (1996-12-01), None
patent: WO 97 48729 (1997-12-01), None
patent: WO 99/15191 (1999-04-01), None
patent: WO 99/21966 (1999-05-01), None
patent: WO 00/05260 (2000-02-01), None
patent: WO 00/13650 (2000-03-01), None
Konishi et al. Brain Research. 1993, 609:29-35.
Gage et al. “Mammalian Neural Stem Cell”. Science. Feb. 2000. vol. 287, pp. 1433-1438.
Cerami et al. Seminars in Oncology, (Apr. 2001), vol. 28, No. 2, Suppl 8, pp. 66-70.
Kandel et al. “Principles of Neural Science”. 1991, p. 981.
Phelps, C.J. et al., “Pituitary hormones as neurotrophic signals: Update on hypothalamic differentiation in genetic models of altered feedback”,Proceedings of the Society for Experimental Biology and Medicine,222(1):39-58 (1999).
Phelps, C.J, et al., “Stimulatory effect of human, but not bovie, growth hormone expression on numbers of tuberoinfundibular dopaminergic neurons in transgenic mice”,Endocrinology,138(7):2849-2855 (1997).
Sorokan, et al., “Erythropoietin mediates increased neurogenesis by embryonic CNS stem cells following a modest hypoxic insult”,Society for Neuroscience Abstracts,23(1/2):320 (1997).
Dicco-Bloom et al., “The PACAP Ligand/Receptor System Regulates Cerebral Cortical Neurogenesis”, Annals of the New York Academy of Sciences, pp. 274-289 (1998).
Lee et al., “Pituitary Adenylyl Cyclase-Activating Polypeptide Stimulates DNA Synthesis but Delays Maturation of Oligodendrocyte Progenitors”, Journal of Neuroscience, vol. 21, No. 11, pp. 3849-3859 (2001).
Bernichtein, S., et al. S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist. Endocrinology 142(9):3950-3963 (2001).
Fernandez-Pol, J.A. Epidermal growth factor receptor of A431 cells. Characterization of a monoclonal anti-receptor antibody noncompetitive agonist of epidermal growth factor action. J. Biol. Chem. 260(8):5003-5011 (1985).
Johnson, D.L., et al. Erythropoietin mimetic peptides and the future. Nephrol. Dial. Transplant. 15(9):1274-1277 (2000).
Kaushansky, K. Hematopoietic growth factor mimetics. Ann. N.Y. Acad. Sci. 938:131-138 (2001).
Kolb, B., et al. Nerve growth factor treatment prevents dendritic atrophy and promotes recovery of function after cortical injury. Neuroscience 76(4):1139-1151 (1997).
Livnah, O., et al. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science 273(5274):464-471 (1996).
Mode, A., et al. The human growth hormone (hGH) antagonist G120RhGH does not antagonize GH in the rat, but has paradoxical agonist activity, probably via the prolactin receptor, Endocrinology 137(2):447-454 (1996).
Moro, O., et al. Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type I receptor agonist. J. Biol. Chem. 272(2):966-70 (1997).
Rochefort, C., et al. Enriched odor exposure increases the number of newborn neurons in the adult olfactory bulb and improves odor memory. J. Neurosci. 22(7):2679-2689 (2002).
Shimazaki, T., et al. The ciliary neurotrophic factor/leukemia inhibitory factor/gp130 receptor complex operates in the maintenance of mammalian forebrain neural stem cells. J. Neurosci. 21(19):7642-7653 (2001), Oct.
Shingo, T., et al. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci. 21(24):9733-9743 (2001), Dec.
Wrighton, N.C., et al. Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273(5274):458-464 (1996).
Shingo Tetsuro
Thompson Bradley G.
Weiss Samuel
Fish & Richardson P.C.
Garnett Daniel C
Romeo David
Stem Cell Therapeutics Inc.
LandOfFree
Combined regulation of neural cell production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined regulation of neural cell production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined regulation of neural cell production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3596425